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Even a brief exposure to severe stress strengthens synaptic connec-
tivity days later in the amygdala, a brain area implicated in the
affective symptoms of stress-related psychiatric disorders. However,
little is known about the synaptic signaling mechanisms during
stress that eventually culminate in its delayed impact on the amygdala.
Hence, we investigated early stress-induced changes in amygdalar
synaptic signaling in order to prevent its delayed effects. Whole-cell
recordings in basolateral amygdala (BLA) slices from rats revealed
higher frequency of miniature excitatory postsynaptic currents
(mEPSCs) immediately after 2-h immobilization stress. This was rep-
licated by inhibition of cannabinoid receptors (CB1R), suggesting a
role for endocannabinoid (eCB) signaling. Stress also reduced N-
arachidonoylethanolamine (AEA), an endogenous ligand of CB1R.
Since stress-induced activation of fatty acid amide hydrolase (FAAH)
reduces AEA, we confirmed that oral administration of an FAAH
inhibitor during stress prevents the increase in synaptic excitation
in the BLA soon after stress. Although stress also caused an imme-
diate reduction in synaptic inhibition, this was not prevented by
FAAH inhibition. Strikingly, FAAH inhibition during the traumatic
stressor was also effective 10 d later on the delayed manifestation
of synaptic strengthening in BLA neurons, preventing both enhanced
mEPSC frequency and increased dendritic spine-density. Thus, oral
administration of an FAAH inhibitor during a brief stress pre-
vents the early synaptic changes that eventually build up to hy-
perexcitability in the amygdala. This framework is of therapeutic
relevance because of growing interest in targeting eCB signaling
to prevent the gradual development of emotional symptoms and
underlying amygdalar dysfunction triggered by traumatic stress.
eCB | stress | BLA | FAAH
Growing evidence points to contrasting features of stress-induced plasticity in the amygdala versus the hippocampus,
both of which are essential components of the neural circuitry
mediating stress responses (1). Stress-induced modulation of
amygdalar structure and function is also unique in its temporal
profile. For example, a single 2-h episode of immobilization trig-
gers a delayed onset of anxiety-like behavior and spinogenesis in
the basolateral amygdala (BLA) not 1 d, but 10 d later (2). Re-
cently, electrophysiological correlates of this delayed spinogenesis
have been identified—the same acute stress also enhances pre-
synaptic glutamate release onto BLA principal neurons 10 d later
(3). However, molecular signaling mechanisms underlying these
delayed changes spanning both sides of the synapse, increase in
postsynaptic spine density and presynaptic glutamate release, remain
largely unexplored.
Several features of this rodent model of acute stress and its
delayed impact are reminiscent of facets of posttraumatic stress
disorder (PTSD), wherein a single, traumatic event triggers changes
in affective behaviors that are both delayed and prolonged and
are accompanied by amygdalar hyperactivity (4, 5). In our
search for potential mechanisms underlying these delayed ef-
fects of acute stress in the BLA, we took note of reports sug-
gesting that aberrations in endocannabinoid (eCB) signaling
could play a key role in the etiology of PTSD, as well as the
prevalence of cannabis use in PTSD patients to cope with their
symptoms (6). The eCB system is a neuromodulatory system
that not only plays a pivotal role in experience-dependent syn-
aptic plasticity; it also links postsynaptic changes with presynaptic
transmitter release (7). Specifically, this system acts through 2 post-
synaptically derived ligands—N-arachidonylethanolamine (ananda-
mide; AEA) and 2-arachidonoylglycerol (2-AG)—that suppress
presynaptic transmitter release through the activation of can-
nabinoid receptors (CB1R) localized in excitatory and inhibitory
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axon terminals (7). In the BLA, the eCB system, particularly
AEA and the activity of its primary metabolic enzyme fatty acid
amide hydrolase (FAAH), is modulated by stress (8–10). Im-
portantly, inhibition of FAAH activity prevents the effects of
chronic stress on structural plasticity in the amygdala and
anxiety-like behavior in rodents (11–13).
However, these earlier findings were based primarily on the
immediate effects of stress. Nothing is known about if and how
eCB signaling contributes to the delayed impact of a brief stressor
in the BLA. Therefore, the current study examines whether the
eCB system and FAAH activity in particular play a role during
acute immobilization stress that eventually leads to the delayed
strengthening of both physiological and structural synaptic con-
nectivity in the BLA days after the termination of stress.
Results
Stress Increases mEPSC Frequency in the BLA, an Effect That Is Mimicked
by CB1R Blockade. In order to assess the immediate impact of acute
stress, whole-cell voltage-clamp recordings were used to measure
miniature AMPAR-mediated excitatory synaptic currents (mEPSCs)
from BLA principal neurons in brain slices (Fig. 1 A and B). This
analysis revealed a significant enhancement in mEPSC frequency
(Fig. 1 C, Left), but not amplitude (Fig. 1 C, Right), 15 min after
acute stress.
As acute disruption of eCB signaling produces a plethora of
neurobehavioral and endocrine responses akin to an acute stress
response (14), we speculated that loss of eCB signaling may re-
sult in changes similar to what is seen following acute stress.
Therefore, we determined whether blocking CB1R in vivo results
in increased mEPSC frequency in the same time frame. Ex vivo
brain slices obtained 2 h after systemic administration of the
CB1R antagonist AM-251 exhibited a significant increase in
mEPSC frequency without any effect on mEPSC amplitude in
BLA neurons (Fig. 1 D–F).
While AEA is believed to mediate tonic eCB signaling in the
BLA (14), there are currently no available tools to inhibit AEA
synthesis and verify this. Instead, we capitalized on the recently
developed DAGL inhibitor DO34, which effectively quenches
2-AG signaling to determine if 2-AG contributes to tonic regu-
lation of glutamatergic transmission in the BLA (15). Unlike
what was seen with direct CB1 receptor blockade, no statistically
significant difference was observed in mEPSC frequency and
amplitude preincubated and perfused with DO34 compared to
vehicle (SI Appendix, Fig. S1 A and B). In addition, no effect of
DO34 was observed on frequency and amplitude of miniature
inhibitory postsynaptic currents (mIPSCs) recorded from BLA
principal neurons (SI Appendix, Fig. S1C). Together, these re-
sults suggest that tonic endocannabinoid tone in the BLA is not
mediated by 2-AG and support the hypothesis that it is driven by
AEA signaling.
Characterization of FAAH Inhibition in the BLA. Given that the cur-
rent data suggest that AEA, not 2-AG, represents the primary
“tonic” signaling molecule of the eCB system in the BLA, we
explored whether acute stress-induced loss of AEA signaling in
the BLA contributes to the increase in mEPSC frequency reported
above. AEA concentrations were increased by pharmacologically
inhibiting FAAH, the enzyme that degrades AEA and shows an
increase in activity with stress (8). A noninvasive and nonstressful
means of administering FAAH inhibitors was utilized in which
50 mg/kg/day of FAAH inhibitor (FAAH-I) was incorporated
into the food (see Materials and Methods). This treatment ap-
proach did not affect food consumption. Animals treated with
FAAH-I exhibited decreased maximal velocity of AEA hydrolysis
by FAAH (Fig. 2 A and B). BLA AEA (Fig. 2C), but not 2-AG
(Fig. 2D), concentrations were significantly elevated by FAAH-I
treatment.
Stress Reduces AEA Concentrations and FAAH-I Reverses Stress-
Induced Increase in mEPSC Frequency in BLA. Consistent with pre-
vious studies examining other stressors (8–10), acute immobili-
zation stress resulted in a significant reduction in the BLA AEA
content (Fig. 3 A, Left and C). mEPSCs were recorded from BLA
neurons following FAAH-I treatment in control and stressed rats
(Fig. 3 A, Right). Consistent with our initial studies, stress exposure
in vehicle-treated animals resulted in higher mEPSC frequency
compared to vehicle-treated control animals (Fig. 3 B, Top). The
stress-induced enhancement in mEPSC frequency did not occur in
animals treated with FAAH-I before stress; mEPSC frequency
in FAAH-I–treated, stressed rats was comparable to frequency
in control-vehicle animals and significantly less than stress-vehicle
animals (Fig. 3 B, Bottom and Fig. 3 D, Left). FAAH-I adminis-
tration alone in control animals did not cause any change in
mEPSC frequency. mEPSC amplitude was not affected by either
stress or FAAH-I administration (Fig. 3 D, Right).
Reversal of Stress Effects Caused by FAAH-I Is Prevented by Systemic
Administration of AM-251 during Stress. Finally, to determine if this
effect of FAAH inhibition was mediated by AEA signaling at
CB1R, rats were simultaneously treated with both FAAH-I and
AM-251 during acute stress (Fig. 4A). AM-251 was injected i.p.
immediately at the onset of stress in the immobilization bag,
while FAAH-I was delivered through food as described earlier.
mEPSC frequency in FAAH-I–treated animals receiving AM-
251 during stress was significantly different from FAAH-I–
treated animals receiving vehicle injection during stress (Fig. 4 B
and C, Left), indicating that inhibition of CB1R reverses the
protective role of FAAH-I against stress-induced increase in
glutamatergic transmission. Importantly, mEPSC frequency in
the FAAH-I/AM-251 group did not differ from mEPSC frequency
Fig. 1. Acute stress and CB1R blockade increases mEPSC frequency in BLA
principal neurons. (A) Schematic of part of a coronal section of the rat brain
containing the BLA, showing location of recording electrode (Left). Experi-
mental design depicting timeline of stress (2 h) followed by tissue collection
after the termination of stress for mEPSC recordings (Right). (B) Represen-
tative mEPSC traces from control and stressed animals. (Scale bar, 30 pA, 5 s.)
(C) After 2 h of acute stress, BLA neurons from the stressed group exhibited
a significant increase (control: n = 12, stress: n = 12, t[13.29] = 3.701, P =
0.0026, **P < 0.01) in mEPSC frequency (Left), but not mEPSC amplitude
(Right). (D) Experimental design depicting i.p. injection of either vehicle
(Veh) or AM-251 in controls, followed by mEPSC recordings. (E) Represen-
tative mEPSC traces. (Scale bar, 30 pA, 5 s.) (F) BLA neurons from the AM-
251–treated group exhibited a significant increase (vehicle: n = 11, AM-251:
n = 15, t[22.06] = 2.411, P = 0.0247, *P < 0.05) in mEPSC frequency (Left).
mEPSC amplitude was not affected by AM-251 (Right).
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recorded in stressed animals, providing additional support for
the reversal of the effect of the FAAH-I by AM-251. In addition,
antagonism of CB1R during stress alone did not elevate mEPSC
frequency (SI Appendix, Fig. S2). Mean mEPSC amplitudes were
not different between the 2 groups (Fig. 4 C, Right).
FAAH-I Does Not Change Stress-Induced Decrease in mIPSC Frequency
in BLA Neurons. CB1R also modulates synaptic inhibition in the
amygdala (16, 17); hence, we examined the impact of FAAH
inhibition on stress-induced alterations in GABAergic synaptic
transmission. GABAA-mIPSCs in BLA neurons taken from
control and stressed animals that were treated with vehicle or
FAAH-I (Fig. 5A). In contrast to what was seen with mEPSCs,
acute stress in vehicle-treated animals resulted in a reduction in
mIPSC frequency compared to vehicle-treated control animals
(Fig. 5 B, Top and Fig. 5 C, Left). Strikingly, FAAH inhibition
had no effect on the stress-induced decrease in mIPSC frequency
(Fig. 5 B, Bottom and Fig. 5 C, Left). No difference was observed
in mIPSC amplitudes across the groups (Fig. 5 C, Right). Hence,
FAAH and AEA do not regulate stress-induced changes in
synaptic inhibition in the BLA.
Stress Enhances 2-AG and Reduces mIPSC Frequency. Two hours of
acute immobilization stress produced a significant increase in
2-AG content within the BLA (Fig. 6 A, Left and Fig. 6B). This is
consistent with recent electrophysiological findings suggesting
that stress-induced release of 2-AG within the BLA suppresses
GABA release and promotes anxiety (18). Hence, we reasoned
that stress-induced increase of 2-AG would result in decreased
inhibitory drive, and CB1R blockade would eliminate this alter-
ation. mIPSCs were compared in BLA taken from vehicle- and
AM-251–treated, control and stressed rats (Fig. 6 A, Right). BLA
neurons from stressed animals exhibited a significant decrease in
mIPSC frequency compared to controls (Fig. 6 C, Top and Fig.
6D). Rats treated with AM-251 during stress had mIPSC fre-
quency levels comparable to both vehicle-treated and AM-251–
treated control animals (Fig. 6 C, Bottom and Fig. 6 D, Left).
Thus, blockade of CB1R using AM-251, while having no impact
on basal mIPSC frequency, prevented stress-induced reduction
in mIPSC frequency in the BLA. Consistent with previous re-
ports (18), these data suggest that stress-induced release of 2-AG
reduces synaptic inhibition in the BLA.
FAAH-I Prevents the Delayed Increase in mEPSC Frequency and Spine
Density in the BLA 10 d after Acute Stress. The acute immobilization
stress protocol used here has previously been shown to trigger a
delayed increase in dendritic spine-density and excitatory synaptic
currents in the BLA 10 d later (3). Given that inhibition of FAAH
reduced the increased glutamate release onto BLA pyramidal
neurons in response to stress, we hypothesized that FAAH in-
hibition would prevent the delayed synaptic effects of acute stress
on BLA neurons 10 d later. Rats were administered FAAH-I or
vehicle for 4 consecutive days before exposure to 2 h of immobi-
lization stress. mEPSC recordings from BLA neurons (Fig. 7A) in
brain slices prepared from these animals revealed stress-induced
increase in mEPSC frequency in vehicle-treated rats 10 d later
(Fig. 7 B, Top and Fig. 7 C, Left), which is consistent with earlier
reports (3). In contrast, FAAH-I treatment before the acute stress
prevented the delayed increase in mEPSC frequency; FAAH-I did
not affect mEPSCs in control rats (Fig. 7 B, Bottom and Fig. 7 C,
Left). mEPSC amplitudes did not differ between the 4 groups (Fig.
7 C, Right). As our current data indicate that stress reduces AEA
signaling to facilitate excitatory transmission in the BLA and that
disruption of tonic AEA/CB1 receptor signaling via AM-251 ad-
ministration recapitulates the effects of stress, we also examined if
there were protracted effects of AM-251 on mEPSC in the BLA
similar to what was seen following stress. As was seen following
acute stress exposure, AM-251 was also found to result in in-
creased mEPSC frequency 10 d later (SI Appendix, Fig. S3). This
demonstrates that a loss of tonic AEA/CB1 receptor signaling in
the BLA is not only sufficient to produce acute elevations in ex-
citatory transmission in the BLA, as does stress, but also results in
sustained changes in BLA excitability.
Finally, to determine if the stress-induced changes in mEPSC
that were attenuated by FAAH inhibition also related to ana-
tomical changes in BLA neurons, we examined the effects of FAAH-
I administration on stress-induced increase in spine-density in
BLA principal neuron 10 d after acute stress. Spine numbers on
Fig. 3. Acute stress reduces AEA, and FAAH inhibitor blocks acute stress-
induced immediate increase in mEPSC frequency in BLA neurons. (A) Ex-
perimental design depicting timeline of stress (2 h) followed by tissue col-
lection (Left) and timeline of FAAH-I administration followed by mEPSC
recordings after stress (Right). (B) Representative mEPSC traces. (Scale bar,
30 pA, 5 s.) (C) Acute stress results in a significant reduction in tissue content
of AEA within the amygdala (control, n = 12; stress, n = 12; t(21.36) = 2.195;
P = 0.0390, *P < 0.05). (D) Vehicle (Veh)-treated stressed group (n = 13) has a
significantly higher mEPSC frequency compared to vehicle-treated controls
(n = 14). FAAH-I before stress (n = 13) led to reduced mEPSC frequency.
FAAH-I in controls (n = 13) did not cause change in mEPSC frequency. (In-
teraction, F[1,49] = 16.12; P = 0.0002, ***P < 0.001; Left). Summary of av-
erage mEPSC amplitudes (Right).
Fig. 2. FAAH inhibitor characterization. (A) Experimental design depicting
timeline of FAAH-I administration followed by tissue collection. (B) Systemic
administration of the FAAH-I significantly decreases the maximal velocity (Vmax)
of AEA hydrolysis by FAAH (vehicle [Veh]: n = 4, FAAH-I: n = 4, t[3.055] = 6.963,
P = 0.0057, **P < 0.01). (C) AEA content within the BLA significantly increases
after FAAH-I treatment (vehicle: n = 4, FAAH-I: n = 4, t[4.652] = 13.04, ***P <
0.0001). (D) FAAH-I does not alter 2-AG levels in the BLA (vehicle: n = 4, FAAH-I:
n = 4, t[5.094] = 0.1210, P = 0.9084).
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primary dendritic branches of Golgi-stained BLA principal neurons
were quantified (Fig. 7D). Consistent with earlier studies, stress
exposure caused a significant increase in the number of spines in
vehicle-treated rats 10 d later (2, 3). However, FAAH-I treatment
prevented this delayed increase in BLA spine-density in stressed
rats (Fig. 7 E, Left). We followed this up with a detailed analysis of
spine density along 10-μm segments of dendrite. This showed how
the prevention of delayed spinogenesis by FAAH-I is distributed
across primary apical dendrites (Fig. 7 E, Right). Together, these
results establish how inhibition of FAAH during acute stress not
only prevents its delayed impact on enhanced mEPSC frequency,
but also blocks the delayed increase in spine density 10 d later.
Discussion
Here we explored the mechanism underlying how a single ex-
posure to 2 h immobilization stress culminates 10 d later in
synaptic changes in the BLA that include increased synaptic
excitability and new spines. Using electrophysiological analyses
in ex vivo BLA slices obtained 15 min after the end of stress, our
results demonstrate enhanced mEPSC frequency. In vivo in-
hibition of CB1Rs replicated this increase in excitatory gluta-
matergic transmission, suggesting that tonic eCB signaling is
involved in the maintenance of glutamatergic transmission in the
BLA. This effect was not recapitulated following local depletion
of 2-AG, suggesting that AEA likely mediates tonic control of
glutamatergic transmission in the BLA. To further explore the
nature of this relationship under conditions of stress, we probed
the regulatory role of FAAH, the enzyme that hydrolyzes the
endogenous CB1R ligand AEA and whose activity increases after
acute stress (8, 10). We found that noninvasive, oral adminis-
tration of an FAAH-I prevented the increase in mEPSC fre-
quency in BLA slices immediately after stress. FAAH-I treatment
prior to stress prevented both the delayed morphological (increase
in the number of dendritic spines) and electrophysiological strength-
ening (higher mEPSC frequency) of BLA synapses caused by acute
stress. This is consistent with previous reports that ablation of
FAAH can prevent dendritic structural plasticity produced by
exposure to chronic stress or corticosterone (11, 12).
What are the potential mechanisms involving modulation of
eCB signaling and synaptic transmission in the BLA that enable
inhibition of FAAH activity to prevent the impact of stress on
BLA synaptic connectivity? While in a previous study we reported
that the same acute stress enhanced presynaptic release of glutamate,
as evidenced by higher mEPSC frequency 10 d later (3), we now
show that it also increases mEPSC frequency immediately after
stress. This adds to accumulating evidence on enhanced gluta-
matergic synaptic transmission in the BLA following other
stressors (19–21). Numerous reports have suggested that tonic or
constitutive eCB/CB1R signaling constrains activation of stress
responsive systems in the brain at rest and that disruption of this
signal can produce neural, endocrine, and behavioral responses
akin to what is seen following acute stress. Specifically, acute
disruption of eCB signaling increases activation of the hypo-
thalamic–pituitary–adrenal axis, induces c-fos expression in neural
circuits mediating the stress response, increases behavioral indices
of anxiety, and impairs fear extinction (9, 14, 22–24). Here we pro-
vide direct physiological evidence that pharmacological inhibi-
tion of eCB signaling also increases glutamatergic transmission,
similar to acute stress.
These findings suggest a model in which increased activation
of the enzyme FAAH reduces AEA content following exposure
to stress, which facilitates excitatory synaptic transmission by
relieving tonic eCB-mediated suppression of synaptic glutamate
release. Our group has previously demonstrated that cortico-
tropin-releasing hormone (CRH) mediates the stress-induced
increase in FAAH (11), and it has also been reported that corti-
costerone can also facilitate glutamate release in the BLA via a
presynaptic mineralocorticoid receptor (MR)-mediated mecha-
nism (20). As such, these data would suggest that both stress-
mediators CRH and corticosterone may coordinately increase
glutamate release in the BLA on differing time scales, with CRH
perhaps rapidly producing these changes through dynamic effects
on AEA signaling, as is demonstrated in the current paper, while
progressive increases in corticosterone following stress enhance
this process via MR in the BLA.
Consistent with earlier reports (18, 25), exposure to stress
reduced mIPSCs, but this was not affected by FAAH inhibition.
Interestingly, the suppression of GABA release was partially
reversed by the CB1R antagonist AM-251 and was accompanied
by increased 2-AG content in the BLA, suggesting that reduced
Fig. 4. Rescue of mEPSC frequency by FAAH inhibitor in BLA neurons is
prevented by blocking CB1R during stress. (A) Experimental design depicting
timeline of FAAH-I administration followed by either vehicle (Veh) or AM-
251 i.p. injection during stress. (B) Representative mEPSC traces. (Scale bar, 20
pA, 3 s.) (C) mEPSC frequency (Left) in the FAAH-I–treated group (n = 13)
which received an i.p. injection of AM-251 is significantly different (Mann–
Whitney U test, U = 25, P = 0.025, *P < 0.05) from the FAAH-I–treated group
which receive vehicle injection (n = 9) during stress. Summary of mEPSC am-
plitudes (Right).
Fig. 5. FAAH inhibitor does not change acute stress-induced immediate de-
crease in mIPSC frequency in BLA neurons. (A) Experimental design. (B) Rep-
resentative mIPSC traces. (Scale bar, 50 pA, 5 s.) (C) Vehicle (Veh)-treated
stressed group (n = 14) has lower mIPSC frequency compared to vehicle-
treated controls (n = 12). FAAH-I before stress (n = 12) also reduced mIPSC
frequency compared to FAAH-I treatment in controls (n = 13) as well as
vehicle-treated controls (stress: F[1,47] = 9.18, P = 0.004; drug: F[1,47] = 0.03,
P = 0.87; interaction: F[1,47] = 0.07, P = 0.79), *P < 0.05) (Left). Summary of
average mIPSC amplitudes illustrates no difference between the groups (Right).
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inhibitory tone in the BLA in response to stress was mediated, in
part, by an increase in 2-AG signaling, which is consistent with
previous reports (18). This ability of AEA to preferentially target
glutamatergic CB1 receptors, while 2-AG may have a greater
influence on GABAergic CB1 receptors, is consistent with pre-
vious physiological, neurochemical, and behavioral reports and
may have implications for drugs targeting FAAH versus mono-
acylglycerol lipase for the potential treatment of stress-related
disorders given the differential effects these approaches may
have on excitability of the BLA, as well as the generation of fear
and anxiety (26, 27).
The loss of synaptic inhibition following stress, coupled to the
higher levels of synaptic glutamate in the BLA during and soon
after stress, is likely to act to enhance the excitability of BLA
pyramidal neurons. Thus, our working model is that elevations in
AEA/CB1R signaling following FAAH inhibition counter the
delayed effects of stress on the BLA through an attenuation of
afferent excitatory drive. With respect to potential mechanisms
that could translate the enhanced release of glutamate triggered
immediately after acute stress into long-term synaptic changes
that are eventually evident 10 d later, we have recently identified
a role for N-methyl-D-aspartate (NMDA) receptors in the BLA
during acute stress in the delayed formation of dendritic spines
(3). This raises the possibility that enhanced glutamate levels, by
activating NMDA receptors in the BLA, could lead to an ideal
synaptic substrate for spinogenesis. Such a scenario would be
consistent with accumulating evidence that long-term potentia-
tion leads to creation of new dendritic protrusions and spines
(28, 29). Additionally, long-term potentiation is known to de-
pend on NMDA receptors, both of which are enhanced in the
BLA following stress. Finally, brain-derived neurotrophic factor
(BDNF) is a potent regulator of morphological plasticity of
dendritic spines in various brain regions. The same acute stress
used here is known to cause a robust increase in BDNF levels in
the BLA (30). Specifically, the highest levels of BDNF in the
BLA were seen 1 d after acute stress, and 10 d later, the BLA
continued to express significantly elevated levels of BDNF (30).
Collectively, these mechanisms could mediate the progressive
increase in spines on BLA pyramidal neurons following stress.
As such, AEA could influence these delayed changes by its
ability to acutely dampen stress-induced glutamate release.
From a translational perspective, this model may also help to
explain how genetic variance in the FAAH gene can modulate
anxiety and activation of the amygdala in response to stress. In
humans, there is a single-nucleotide polymorphism (P129T FAAH
SNP; rs324420) that exists within the FAAH gene that results in a
consequential reduction in FAAH expression and a moderate
facilitation of AEA signaling (31). Interestingly, humans bearing
Fig. 6. Acute stress enhances 2-AG and results in CB1R-mediated reduction
in mIPSC frequency in BLA principal neurons. (A) Experimental design
depicting timeline of stress (2 h) followed by tissue collection (Left) and
stress followed by immediate i.p. injection of either vehicle (Veh) or AM-251,
in addition to their respective controls (Right) for mIPSC recordings. (B)
Acute stress results in a significant enhancement of 2-AG within the amyg-
dala (control: n = 12, stress: n = 12, t [22] = 2.094, P = 0.048, *P < 0.05). (C)
Representative mIPSC traces. (Scale bar, 50 pA, 5 s.) (D) Vehicle-treated
stressed group (n = 15) has significantly lower mIPSC frequency compared
to vehicle-treated controls (n = 14). Group treated with AM-251 during stress
(n = 11) has mIPSC frequency comparable to AM-251–treated controls (n =
15). (Stress: F[1,51] = 5.58, P = 0.02; drug: F[1,51] = 1.26, P = 0.27; interaction:
F[1,51] = 0.38, P = 0.54, *P < 0.05 (Left). Summary of average mIPSC am-
plitudes (drug: F[1,51] = 4.84, P = 0.03) (Right).
Fig. 7. Stress-induced delayed increase in mEPSC frequency and spine
density in BLA principal neurons is blocked by FAAH-I. (A) Experimental
design depicting timeline of FAAH-I administration followed by stress, 10 d
after which either mEPSC recordings were done or brains were processed
for spine analysis. (B) Representative mEPSC traces. (Scale bar, 30 pA, 5 s.)
(C ) Vehicle (Veh)-treated stressed group has increase in mEPSC frequency
10 d after stress. This delayed increase is not observed in the FAAH-I–
treated stressed group (control/vehicle: n = 16, stress/vehicle: n = 16,
stress/FAAH-I: n = 16, control/FAAH-I: n = 16; stress: F[1,60] = 11.79, P =
0.001; drug: F[1,60]= 6.04, P = 0.02; interaction: F[1,60] = 10.91, P = 0.002,
***P < 0.001 (Left). Summary of average mEPSC amplitudes shows no
difference between the 4 groups (Right). (D) Low-power photomicrograph
of a Golgi stain-impregnated pyramidal neuron in the BLA (20×; Scale bar,
10 μm) (Left). Representative images of primary dendrites of BLA pyra-
midal neurons (40×; Scale bar, 10 μm) (Right). (E ) Analysis of total number
of spines on a primary branch of pyramidal neurons in the BLA shows an
increase in spine density in the vehicle-treated stressed group (n = 25)
compared to vehicle-treated controls (n = 29). FAAH-I treatment (n = 25)
rescues stress-induced increase in spines in the BLA (one-way ANOVA,
F[2,76] = 58.17, ***P < 0.001) (Left). Segmental analysis of dendritic spine
density in each successive 10-μ segment along a primary branch in the
pyramidal neurons in the BLA as a function of distance of that segment
from the origin of the branch. Significant differences observed are indicated
(for stress/vehicle vs. stress/FAAH-I) as follows: *P < 0.05, **P < 0.01 (repeated
measures two-way ANOVA, Tukey’s multiple comparisons test) (Right).
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the SNP have been found to exhibit blunted activation of the
amygdala in response to stressful stimuli, reduced responses to
stress, accelerated fear extinction, and lower indices of anxiety.
Consistent with our data, it is likely that the protective effect of the
P129T FAAH SNP may relate to its ability to prevent stress-
induced loss of AEA signaling within the amygdala (32), which
would then restrict activation of the BLA to limit the magnitude of
a stress response.
Hyperactivity of the amygdala is a hallmark finding in PTSD
and is believed to relate to excess anxiety and high levels of
arousal seen in the disorder (33). The formation of new spines on
amygdala neurons from stress exposure or genetic mutation has
been linked to enhanced fear and anxiety-like behavior in ro-
dents (1, 2, 11). Thus, our rodent model of stress is attractive in
relation to PTSD because it leads to a progressive development
of anxiety that is manifested well after the acute stressor and is ac-
companied by cellular changes in brain structure implicated in the
emotional symptoms of PTSD (2, 6). As such, the current data
suggest that inhibition of FAAH could reduce hyperactivity of the
amygdala and thus potentially act as a novel treatment approach for
PTSD. However, FAAH inhibitor administration via the chow does
not specifically rule out the possibility that the blockade could be
occurring outside the BLA as well. Therefore, whether targeted
blockage of FAAH in the BLA alone will be sufficient for alleviating
the effects of stress is an important topic for future investigations.
Finally, while this study tells us that intervention during stress
prevents its delayed effects, it also offers a framework to explore
therapeutically relevant questions about interventions after stress.
Specifically, future studies will be required to examine time-windows
after the termination of stress wherein FAAH inhibitors would
still be effective in blocking the delayed strengthening of synaptic
connectivity in the BLA. In addition, use of a noninvasive, oral ad-
ministration of an FAAH inhibitor highlights its therapeutic rele-
vance. Such studies are likely to give rise to new experimental
paradigms that will help us better understand and intervene
against molecular and synaptic mechanisms linking traumatic
stress to its eventual manifestation as debilitating psychiatric
conditions.
Materials and Methods
Animals, stress, electrophysiology, staining, drug administration, endocannabinoid
extraction, FAAH activity assay, and statistical analyses are described in SI
Appendix. The Institutional Animal Ethics Committee at the Rockefeller Uni-
versity, University of Calgary, and National Centre for Biological Sciences ap-
proved all procedures related to animal maintenance and experimentation.
Chemicals. AM-251 was obtained from Tocris Bioscience, TTX and QX-314 from
Alomone Labs. FAAH-I JNJ-40355003 was provided courtesy of Johnson &
Johnson pharmaceuticals (34). All other drugs were from Sigma-Aldrich.
Data availability. All data discussed in the paper are available in SI Appendix
and Datasets S1–S10.
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